Navigation Links
Mesoblast Cleared to Begin First Phase 2 Clinical Trial for Eye Diseases
Date:10/24/2011

ecurrence and risk of vision loss.

In Asia, wet AMD affects as many as 1.9% of people 65 or older. However, up to 55% of cases of wet AMD in Chinese, Japanese, and Malay populations are caused by Polypoid Choroidal Vasculopathy (PCV), a disorder of eye blood vessel proliferation that is different from the wet form seen in North America and Europe. Anti-VEGF therapy does not result in adequate regression of PCV lesions, and for this reason first line therapy for PCV is photodynamic therapy.

Mesoblast's proprietary adult stem cells may be effective for both forms of wet AMD since they have successfully reduced excessive blood vessel formation and leakiness in several preclinical studies:

1.  Results from a study at the Lions' Eye Institute in Western Australia in 30 rodents with laser-induced excessive blood vessel formation showed that a single intra-ocular injection of human MPC prevented development of leaky blood vessels beyond day 7 after laser-induced damage (eyes treated with MPC had 39% and 32% non-leaky vessels at days 14 and 28, compared with only 7% and 2% non-leaky vessels in the controls at the same time-points, p<0.05).  Moreover, at day 28 only 9% of vessels in eyes treated with a single MPC injection were severely leaking compared with 28% of vessels in control eyes (p<0.05).

2.  Results from a trial at Charles River in Canada in 42 non-human primates with laser-induced excessive blood vessel formation showed that combining a single injection of Mesoblast's allogeneic cells with an injection of the anti-VEGF agent Lucentis resulted in a synergistic, and superior, outcome compared with Lucentis alone in reducing severity of blood vessel leakage within 2 weeks (p<0.05), preventing relapse of severe vessel leakage by days 28-42 (p<0.05), reducing total formation of new blood vessels (p<0.01), and preventing retinal detachment by day 42 (p<0.01).

Mesoblast's randomized, placebo-controlle
'/>"/>

SOURCE Mesoblast Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or Off-The-Shelf Stem Cell Treatment for Heart Attacks
2. Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
3. Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth
4. ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
5. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
6. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the United States to Utilize Newly FDA-Cleared CARTO(R) 3 Navigation System
7. Zargis Cardioscan Cleared for Sale in Canada
8. Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia
9. FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre(R) In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoni
10. Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc.
11. Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  A prospective study ... Sweden has validated the performance of ... and has associated volumetrically assessed breast density measurements ... Epidemiology, Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the ... tool for widespread breast cancer risk assessment," was ...
(Date:7/28/2014)... July 28, 2014  TNI BioTech, Inc. (OTCQB: ... focused on the development, marketing and distribution of ... definitive proxy materials with the Securities and Exchange ... of Shareholders to be held on Thursday, September ... The record date for determining those shareholders eligible ...
(Date:7/28/2014)...  ResMed (NYSE: RMD ), an innovator ... sleep-disordered breathing and other chronic respiratory conditions, has won ... against Taiwanese medical device manufacturer APEX Medical Corp. (APEX), ... 210 and 220 masks.  The judgment was entered by ... , is appealable, and applies throughout Germany.  ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... Calif., Oct. 31, 2011 Claret Medical, Inc. announced ... approval as the world,s first complete system of filtration ... is delivered via radial or brachial access, providing complete ... Valve Intervention (TAVI).  The unique design of the Montage ...
... Oct. 31, 2011 At the American ... Renal Research Institute, LLC (RRI) is presenting research results from ... dedicated to advancing therapy options for dialysis patients to provide ... ASN,s Kidney Week 2011 takes place Nov. 8-13 in Philadelphia, ...
Cached Medicine Technology:Claret Medical Announces CE Mark of a New Embolic Protection System to Address Stroke During Transcatheter Aortic Valve Intervention 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 3
(Date:7/28/2014)... is proposing a new theory to explain why older ... necessarily show declines in the workplace or daily life. ... are to maintain focus on cognitive tasks. , "My ... we see in cognitive performance in different settings," says ... State and author of a paper describing the theory. ...
(Date:7/28/2014)... 2014 Alta Resources , a ... for Fortune 500 brands, announced today that it plans ... in Wisconsin, California, Florida and the Philippines. More than ... Brea campus. , A majority of the hiring is ... that require additional staffing in preparation for the Annual ...
(Date:7/28/2014)... New Port Richey, FL (PRWEB) July 28, 2014 ... “a silent killer,” prescription drug abuse causes more fatal ... than 16,500 lives a year. (1) Those who are ... (65 years of age and up), with many in ... daily. (2) Conversation regarding this growing epidemic was reawakened ...
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, 2014 (HealthDay News) -- ... donations from gay and bisexual men, according to a team of ... of the American Medical Association . Currently, a man who ... the United States -- a lifetime ban that has been in ... this policy at the dawn of the AIDS crisis. However, ...
(Date:7/28/2014)... 2014 For those with dust allergies, home ... dust allergies—commonly settle in mattresses, bedding, and upholstered furniture and ... mites are microscopic insects that feed on the dead skin ... to keep a million dust mites fat and happy. When ... microscope, the decaying bodies and feces of dust mites can ...
Breaking Medicine News(10 mins):Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2Health News:Alta Resources to Fill Approximately 700 Positions in Brea 2Health News:Alta Resources to Fill Approximately 700 Positions in Brea 3Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 3Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 4Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 2Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 3Health News:AllergyEasy® Announces No-shots Immunotherapy to Mitigate Dust Allergies 2Health News:AllergyEasy® Announces No-shots Immunotherapy to Mitigate Dust Allergies 3
... to man, and new findings about Alzheimer,s disease have just been ... the entire report about the latest in these cutting edge research ... ... Fla. (PRWEB) November 14, 2008 -- It,s one of the most ...
... to customers purchasing its market leading email and message archiving ... ... (PRWEB) November 14, 2008 -- Privacy Networks, the unified messaging ... customers purchasing Privacy Networks, market leading message PrivacyVault archiving software. ...
... present in the four social environments in which young ... negatively to whether teens misuse alcohol, with risk from ... of another. , That,s the finding of a new ... North Carolina at Chapel Hill, the University of California ...
... do minor behavior problems and experiences early in life ... group of researchers has found that the answer may ... experiences lead to behaviors and new experiences that lead ... behavior. , The researchers found that children who had ...
... best, researchers say , , THURSDAY, Nov. 13 (HealthDay News) ... bowel syndrome (IBS) may be older, cheaper drugs such ... finds. , According to researchers, these simple treatments have ... newer (and more expensive) drugs, some of which have ...
... James G.,Carlson, Chairman and CEO of AMERIGROUP Corporation (NYSE: ... Card," which was,released November 12 by the March of Dimes:, ... to grow up in good,health. But as the March of ... that is not the case today. Studies show that babies,born ...
Cached Medicine News:Health News:Alzheimer's Disease Cutting Edge Research Announced on Natural Health News Report Website 2Health News:Message Archiving Leader Privacy Networks Announces Free Anti-Spam Software to Businesses and Organizations 2Health News:Message Archiving Leader Privacy Networks Announces Free Anti-Spam Software to Businesses and Organizations 3Health News:Families, friends, schools and neighborhoods contribute to adolescent alcohol misuse 2Health News:Cascading effect of even minor early problems may explain serious teen violence 2Health News:Peppermint Oil, Fiber Can Fight Irritable Bowel 2Health News:Peppermint Oil, Fiber Can Fight Irritable Bowel 3Health News:AMERIGROUP Chairman and CEO Urges Action to Improve Nation's 'Premature Birth Report Card' 2
Ergotec Vetriretinal Instrument System. Ultra-fine 2.8 mm jaws. Angled 55 degrees. 20 gauge shaft. 25 mm in length with black tip. Overall length from rear rotation knob to tip....
Triangular shaped tips. Marked for 5 mm and 10 mm tucks. Round knurled handle with polished finish....
Angled shafts with 12 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left. Most popular size or model....
Angled shafts with 11 mm long tips. Jaws have longitudinal meshing serrations. Slide lock and serrated handle with polished finish....
Medicine Products: